News & Events

Investor Center

Careers

Pipeline

Partnership

About  Us

About Us

Research & Development

Research & Development Pipeline Partership Investor Center News & Events Careers
Home

中文

Contact
   Home    Home-Ch
Press Releases
More Ascletis News
News & Events    Home-Ch
© 2016 Ascletis. All Rights Reserved
浙公网安备 33010802003344 号
CONTACT US
pr@ascletis.com
hr@ascletis.com
bd@ascletis.com
clinicaltrials@ascletis.com
Contact

Aug 20, 2017   Zhejiang Initiated Eliminate Hepatitis C Program >>

20170103AscletisSeriesBfinancing.pdf

May 27, 2016   Party Secretary of ShaoXing Mr. Peng Jiaxue Visited Ascletis  >>

20170820Xinhua.pdf

Aug 08, 2017   Ascletis Won the First Prize in China Innovation and Entrepreneurship Competition at Healthcare Sector Final >>

20170808CompetitionCh.pdf

Jul 09, 2017   Zhejiang CPPCC Chairwoman MS. Qiao Chuanxiu Visited Ascletis >>

20170709CPPCC.pdf

Aug 18, 2017   Ascletis In-Licenses  Medivir HCV Drug Candidate  >>

20170818Medivir.pdf

Sep 19, 2017   Ascletis Won the First Prize in the China Innovation and Entrepreneurship Competition at Healthcare Sector Final  >>

20170919FirstPrize.pdf
CCTV Report on HCV
Partnership
IHEPA Interview
Partership XinyueChen.pdf

Guidelines for the HCV Treatment

GuidelinesForHCV2015.pdf
HIV in China
Video
Corporate Member

Ascletis is a specialty therapeutics company dedicated to discovering

and developing important new treatments for cancer and infectious diseases.

HCV IN CHINA

歌礼与您携手

共同抗击肝炎

Together, Cure Hepatitis

7.28 世界肝炎日

World Hepatitis Day